Argitalpenak (43) Cristina Pérez Ruiz argitalpenak

2023

  1. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

  2. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

    Nature Medicine, Vol. 29, Núm. 3, pp. 632-645

  3. Prevalence, incidence and risk factors for acquisition and colonization of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae from dogs attended at a veterinary hospital in Spain

    Comparative Immunology, Microbiology and Infectious Diseases, Vol. 92

  4. Tandem Triplication 11p15.5-ICR1 (H19/IGF2) Detected by Microarray and Optical Genome Mapping in a Prenatal Beckwith-Wiedemann Case

    Cytogenetic and Genome Research, Vol. 163, Núm. 1-2, pp. 32-35

  5. Variation of Plasma Damage-Associated Molecular Patterns in Patients with Advanced Solid Tumors after Standard of Care Systemic Treatment

    Cancer Investigation, Vol. 41, Núm. 10, pp. 821-829

2022

  1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research

  2. Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781

  3. Efficiency of screening for human immunodeficiency virus infection in emergency departments: a systematic review and meta-analysis

    Emergencias, Vol. 34, Núm. 3, pp. 204-212

  4. FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

    Blood Advances, Vol. 6, Núm. 2, pp. 690-703

  5. Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting

    Cancers, Vol. 14, Núm. 18

  6. Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma

    Science Advances, Vol. 8, Núm. 3

2021

  1. Genomic Chaos (Multiple Copy Number Variations and Structural Reorganization) Detected in Two Prenatal Cases

    Cytogenetic and Genome Research, Vol. 161, Núm. 5, pp. 236-242

  2. Immunologic characterization of COVID-19 patients with hematological cancer

    Haematologica

  3. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients

    Frontiers in Immunology, Vol. 12

2020

  1. A New Case with Corpus Callosum Abnormalities, Microcephaly and Seizures Associated with a 2.3-Mb 1q43-q44 Deletion

    Cytogenetic and Genome Research, Vol. 159, Núm. 3, pp. 126-129

  2. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

    Blood, Vol. 136, Núm. 2, pp. 199-209

2019

  1. The mechanism of action of the anti-CD38 monoclonal antibody isatuximab in multiple myeloma

    Clinical Cancer Research, Vol. 25, Núm. 10, pp. 3176-3187

2018

  1. A new model of exercise referral scheme in primary care: Is the effect on adherence to physical activity sustainable in the long term? A 15-month randomised controlled trial

    BMJ Open, Vol. 8, Núm. 3

2017

  1. 18F-FDG PET/CT in the Staging and Management of Breast Cancer: Value in Disease Outcome and Planning Therapy

    Clinical Nuclear Medicine, Vol. 42, Núm. 3, pp. 191-192

  2. Metástasis en ciego de un cáncer lobulillar de mama diagnosticada con 18F-FDG PET/TC

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 6, pp. 408